27 August 2025
27 August 2025
The highest dose of the oral GLP-1RA drug reduced body weight by an average of 10.5%.
In a U-turn from a decision two weeks ago, the FDA – citing new safety events – said the vaccine is a "danger to health".
This 65,000m² facility is Genentech’s first plant on the US East Coast.
Analysts and charities have identified Gilead’s new HIV prevention injection as key to curbing infection rates.
Bretisilocin, a 5-HT2A receptor agonist and 5-HT releaser, has been designed to reduce the duration of psychoactive experience.
As regulators push to phase out animal testing, Charles River’s Steve Bulera notes that widespread implementation of alternative methods will “take time”.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
